Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Cancer Discovery|May 4, 2023
MDM2-PROTAC versus MDM2 Inhibitors: Beyond p53 ReactivationSylvain Peuget, Galina SelivanovaCancers|October 13, 2021
p53-Dependent Repression: DREAM or Reality?Sylvain Peuget, Galina SelivanovaNature Reviews. Cancer|January 29, 2024
Translating p53-based therapies for cancer into the clinicSylvain Peuget, Xiaolei Zhou, Galina SelivanovaJournal of Molecular Cell Biology|July 17, 2019
Inhibition of p53 inhibitors: progress, challenges and perspectivesGema Sanz, Madhurendra Singh, Sylvain Peuget, et al.Scientific Reports|January 25, 2020
Pifithrin-α alters p53 post-translational modifications pattern and differentially inhibits p53 target genesJiawei Zhu, Madhurendra Singh, Galina Selivanova, et al.Scientific Reports|February 22, 2019
Prediction of response to anti-cancer drugs becomes robust via network integration of molecular dataMarcela Franco, Ashwini Jeggari, Sylvain Peuget, et al.Molecular Cancer Therapeutics|July 25, 2022
Decreased DNA Damage and Improved p53 Specificity of RITA AnalogsYue Zhan, Xiaolei Zhou, Sylvain Peuget, et al.Oncogene|February 24, 2022
Enterobacteria impair host p53 tumor suppressor activity through mRNA destabilizationMarie-Stéphanie Aschtgen, Konstantinos Fragkoulis, Gema Sanz, et al.Cell Death & Disease|November 9, 2019
RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activityJohannes Ristau, Vincent van Hoef, Sylvain Peuget, et al.Breast Cancer Research : BCR|July 31, 2020
Identification and targeting of selective vulnerability rendered by tamoxifen resistanceMadhurendra Singh, Xiaolei Zhou, Xinsong Chen, et al.Pageof 7